The Q4 profit of PharmEasy-Owned Thyrocare increases by 25.6% to INR 21.6 Cr.

Thyrocare, a diagnostics platform owned by PharmEasy, saw a 25.6% increase in consolidated net profit from INR 17.2 Cr in the previous quarter to INR 21.6 Cr in the fourth quarter of the fiscal year that ended in March 2025 (Q4 FY25).Thyrocare, a diagnostics platform owned by PharmEasy, saw a 25.6% increase in consolidated net profit from INR 17.2 Cr in the previous quarter to INR 21.6 Cr in the fourth quarter of the fiscal year that ended in March 2025 (Q4 FY25).

Profit rose 14% sequentially from INR 18.95 Cr.46 minutes agoAccording to a recent consumer survey conducted by Counterpoint Research in collaboration with OnePlus, young professionals in India are becoming more interested in small smartphones, but they are also becoming frustrated with the market's lack of options. Because of its mobility and ease of use, 74% of poll participants said they prefer compact telephones. However, according to 68% of respondents, there aren't enough high-quality options in this market, particularly when it comes to flagship-level performance.